TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Glycorex Transplantation AB (publ)
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
30,352
|
34,163
|
27,503 |
Financial expenses |
391
|
234
|
392 |
Earnings before taxes |
-30,760
|
-8,059
|
-11,938 |
EBITDA |
-9,055
|
235
|
-3,266 |
Total assets |
66,702
|
90,880
|
99,277 |
Current assets |
26,478
|
42,982
|
49,304 |
Current liabilities |
14,719
|
14,966
|
13,186 |
Equity capital |
44,613
|
70,341
|
80,898 |
- share capital |
3,740
|
3,492
|
3,601 |
Employees (average) |
23
|
22
|
24 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
66.9%
|
77.4%
|
81.5% |
Turnover per employee |
1,320
|
1,553
|
1,146 |
Profit as a percentage of turnover |
-101.3%
|
-23.6%
|
-43.4% |
Return on assets (ROA) |
-45.5%
|
-8.6%
|
-11.6% |
Current ratio |
179.9%
|
287.2%
|
373.9% |
Return on equity (ROE) |
-68.9%
|
-11.5%
|
-14.8% |
Change turnover |
-6,234
|
7,486
|
1,172 |
Change turnover % |
-17%
|
28%
|
4% |
Chg. No. of employees |
1
|
-2
|
2 |
Chg. No. of employees % |
5%
|
-8%
|
9% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.